Paltusotine
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Developments in Pharmacotherapy for Acromegaly: Current and Emerging Approaches.
Journal: Drugs
Published: January 30, 2026
Current Treatment Landscape of Acromegaly.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 26, 2026
Efficacy and Safety of Pharmacologic Therapies in Acromegaly: A Systematic Literature Review and Network Meta-Analysis.
Journal: The Journal of clinical endocrinology and metabolism
Published: December 23, 2025
Paltusotine and Its Place in the Treatment Armamentarium for Acromegaly.
Journal: The Journal of clinical endocrinology and metabolism
Published: November 22, 2025
A new era in oral treatment for acromegaly with the FDA-approved drug paltusotine.
Journal: Annals of medicine and surgery (2012)
Published: November 11, 2025
Paltusotine Hydrochloride.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: November 09, 2025
Paltusotine: The first selective nonpeptide agonist of somatostatin receptor 2 (SSTR2) for the treatment of acromegaly.
Journal: Drug discoveries & therapeutics
Published: October 29, 2025
Paltusotine: The first FDA approved oral treatment for acromegaly.
Journal: Annals of medicine and surgery (2012)
Published: October 17, 2025
Rapid and Sustained Response of Biochemically Uncontrolled Acromegaly to Once-daily Oral Paltusotine Treatment.
Journal: The Journal of clinical endocrinology and metabolism
Published: June 23, 2025
Paltusotine versus octreotide: different effects on radioligand uptake in neuroendocrine tumours.
Journal: Endocrine oncology (Bristol, England)
Published: April 27, 2025
New treatments for acromegaly: Is a revolution underway?
Journal: Annales d'endocrinologie
Published: February 17, 2025
Last Updated: 04/28/2026